- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Plaque psoriasis
- Meeting Date: March 2022
- Public Summary Document (PSD) March 2022 PBAC Meeting - (PDF 1.1MB)
- Public Summary Document (PSD) March 2022 PBAC Meeting - (Word 288KB)
Bimekizumab – March 2022
Bimekizumab: Solution for injection 160 mg in 1 mL pre-filled pen, Solution for injection 160 mg in 1 mL pre-filled syringe; Bimzelx®
Last updated
1 July 2022